Advertisement
Research Article| Volume 12, ISSUE 1, P41-48, January 2021

Download started.

Ok

The impact of a tailored follow-up intervention on comprehensive geriatric assessment in older patients with cancer - a randomised controlled trial

Published:August 01, 2020DOI:https://doi.org/10.1016/j.jgo.2020.07.011

      Abstract

      Purpose

      Comprehensive Geriatric Assessment (CGA) can identify health problems in older persons. In addition, CGA includes intervention towards the identified problems. With follow up, more problems may be identified and the interventions can be adjusted. We wanted to compare CGA with or without tailored follow-up in a randomised design.

      Patients and Methods

      Patients 70+ years referred for oncology treatment with four primary tumour sites. Participants were randomised 1:1 to either control group with no follow-up or intervention group with a tailored follow-up by a multidisciplinary team. Primary outcome was adherence to cancer treatment. Secondary outcomes were daily life activities, physical performance and hospitalisation.

      Results

      In total, 363 participants were randomised. After randomisation only 301 were planned to receive specific cancer treatment. Median age was 75 years. Among the 301 participants, 52% of control group vs. 61% of intervention group completed treatment. Risk Rate (RR): 1.16 (95% Confidence Interval (CI): 0.95–1.42), p = .14. The impact varied between the included tumour-sites, p < .01. We found no difference in 90 days physical performance or daily life activities between groups. During the study period, 55% of controls vs. 47% in the intervention group were admitted to hospital, RR: 0.86 (95%CI: 0.69–1.07), p = .19.

      Conclusion

      In frail and vulnerable patients with cancer, a tailored follow-up on CGA showed no differences in ability to complete initially planned cancer treatment. The impact varied between the included tumour sites. We did not find any impact of tailored follow-up on daily life activities, physical performance or hospitalisation.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Geriatric Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Danckert B.
        • Ferlay J.
        • Engholm G.
        • Hansen H.
        • Johannesen T.
        • Khan S.
        • et al.
        NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version 8.2 (26.03.2019).
        Association of the Nordic Cancer Registries. Danish Cancer Society, 2019 (Available from. Available at:) (Accessed 06/24, 2019)
        • Engholm G.
        • Ferlay J.
        • Christensen N.
        • Bray F.
        • Gjerstorff M.L.
        • Klint A.
        • et al.
        NORDCAN--a Nordic tool for cancer information, planning, quality control and research.
        Acta Oncol. 2010 Jun; 49: 725-736
        • Ewertz M.
        • Christensen K.
        • Engholm G.
        • Kejs A.M.
        • Lund L.
        • Matzen L.E.
        • et al.
        Trends in cancer in the elderly population in Denmark, 1980-2012.
        Acta Oncol. 2016; 55: 1-6
        • Hutchins L.F.
        • Unger J.M.
        • Crowley J.J.
        • Coltman Jr., C.A.
        • Albain K.S.
        Underrepresentation of patients 65 years of age or older in cancer-treatment trials.
        N Engl J Med. 1999 Dec 30; 341: 2061-2067
        • Javid S.H.
        • Unger J.M.
        • Gralow J.R.
        • Moinpour C.M.
        • Wozniak A.J.
        • Goodwin J.W.
        • et al.
        A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG S0316).
        Oncologist. 2012; 17: 1180-1190
        • Pallis A.G.
        • Ring A.
        • Fortpied C.
        • Penninckx B.
        • Van Nes M.C.
        • Wedding U.
        • et al.
        EORTC workshop on clinical trial methodology in older individuals with a diagnosis of solid tumors.
        Ann Oncol. 2011 Aug; 22: 1922-1926
        • Tack L.
        • Lefebvre T.
        • Lycke M.
        • Pottel L.
        • Cool L.
        • Ketelaars L.
        • et al.
        Underrepresentation of vulnerable older patients with cancer in phase II and III oncology registration trials: a case-control study.
        J Geriatr Oncol. 2020; 11: 320-326https://doi.org/10.1016/j.jgo.2019.09.003
        • Ahmed S.
        • Ahmad I.
        • Zhu T.
        • Arnold F.P.
        • Faiz Anan G.
        • Sami A.
        • et al.
        Early discontinuation but not the timing of adjuvant therapy affects survival of patients with high-risk colorectal cancer: a population-based study.
        Dis Colon Rectum. 2010 Oct; 53: 1432-1438
        • Fesinmeyer M.D.
        • Mehta V.
        • Blough D.
        • Tock L.
        • Ramsey S.D.
        Effect of radiotherapy interruptions on survival in medicare enrollees with local and regional head-and-neck cancer.
        Int J Radiat Oncol Biol Phys. 2010 Nov 1; 78: 675-681
        • Hugar L.A.
        • Yabes J.G.
        • Turner 2nd, R.M.
        • Fam M.M.
        • Appleman L.J.
        • Davies B.J.
        • et al.
        Rate and Determinants of Completing Neoadjuvant Chemotherapy in Medicare Beneficiaries With Bladder Cancer: A SEER-Medicare Analysis Urology.
        124. 2019 Feb: 191-197
        • Laurent M.
        • Brureau L.
        • Demery M.E.
        • Flechon A.
        • Thuaut A.L.
        • Carvahlo-Verlinde M.
        • et al.
        Early chemotherapy discontinuation and mortality in older patients with metastatic bladder cancer: the AGEVIM multicenter cohort study.
        Urol Oncol. 2017 Jan; 35 (34.e9–34.e16)
        • Gupta A.
        • Baxi S.
        • Hoyne C.
        Assessing feasibility, compliance and toxicity of concomitant chemo-radiotherapy in head and neck cancers in the Northern Territory: initial experience and challenges.
        J Med Radiat Sci. 2017 Jun; 64: 131-137
        • Honecker F.
        • Wedding U.
        • Kallischnigg G.
        • Schroeder A.
        • Klier J.
        • Frangenheim T.
        • et al.
        Risk factors for unplanned discontinuation of scheduled treatment in elderly patients with castration-resistant prostate cancer: results of the IBuTu study.
        J Cancer Res Clin Oncol. 2018 Mar; 144: 571-577
        • Wo J.Y.
        • Hong T.S.
        • Kachnic L.A.
        Impact of age and comorbidities on the treatment of gastrointestinal malignancies.
        Semin Radiat Oncol. 2012 Oct; 22: 311-320
        • Middelburg J.G.
        • Mast M.E.
        • de Kroon M.
        • Jobsen J.J.
        • Rozema T.
        • Maas H.
        • et al.
        Timed get up and go test and geriatric 8 scores and the association with (chemo-)radiation therapy noncompliance and acute toxicity in elderly cancer patients.
        Int J Radiat Oncol Biol Phys. 2017 Jul 15; 98: 843-849
        • Palumbo A.
        • Bringhen S.
        • Mateos M.
        • Larocca A.
        • Facon T.
        • Kumar S.
        • et al.
        Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an international myeloma working group report.
        Blood. 2015; 125 (2015/03): 2068-2074
        • Walker M.S.
        • Masaquel A.S.
        • Kerr J.
        • Lalla D.
        • Abidoye O.
        • Houts A.C.
        • et al.
        Early treatment discontinuation and switching in first-line metastatic breast cancer: the role of patient-reported symptom burden.
        Breast Cancer Res Treat. 2014 Apr; 144: 673-681
        • Corre R.
        • Greillier L.
        • Le Caer H.
        • Audigier-Valette C.
        • Baize N.
        • Berard H.
        • et al.
        Use of a comprehensive geriatric assessment for the management of elderly patients with advanced non-small-cell lung cancer: the phase III randomized ESOGIA-GFPC-GECP 08-02 study.
        J Clin Oncol. 2016 May 1; 34: 1476-1483
        • Aaldriks A.A.
        • Maartense E.
        • Nortier H.J.
        • van der Geest L.G.
        • le Cessie S.
        • Tanis B.C.
        • et al.
        Prognostic factors for the feasibility of chemotherapy and the geriatric prognostic index (GPI) as risk profile for mortality before chemotherapy in the elderly.
        Acta Oncol. 2016; 55: 15-23
        • von Gruenigen V.E.
        • Huang H.Q.
        • Beumer J.H.
        • Lankes H.A.
        • Tew W.
        • Herzog T.
        • et al.
        Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer - an NRG oncology/gynecologic oncology group study.
        Gynecol Oncol. 2017 Mar; 144: 459-467
        • Hamid A.A.
        • Willson K.
        • Vincent A.D.
        • Tamjid B.
        • Lee M.
        • Bergin A.
        • et al.
        Risk of febrile neutropenia and early treatment cessation in men receiving standard and dose-reduced 3-weekly docetaxel for metastatic castration-resistant prostate cancer.
        Asia Pac J Clin Oncol. 2018 Oct; 14: e399-e404
        • Sequist L.V.
        • Fidias P.
        Treatment of advanced non-small cell lung cancer in the elderly.
        Semin Respir Crit Care Med. 2005 Jun; 26: 289-297
        • Kalsi T.
        • Babic-Illman G.
        • Fields P.
        • Hughes S.
        • Maisey N.
        • Ross P.
        • et al.
        The impact of low-grade toxicity in older people with cancer undergoing chemotherapy.
        Br J Cancer. 2014 Dec 9; 111: 2224-2228
        • Hayashi N.
        • Matsuoka A.
        • Goto H.
        • Gotoh M.
        • Kiyoi H.
        • Kodera Y.
        • et al.
        Clinical effectiveness of geriatric assessment for predicting the tolerability of outpatient chemotherapy in older adults with cancer.
        J Geriatr Oncol. 2018 Jan; 9: 84-86
        • Kalsi T.
        • Babic-Illman G.
        • Ross P.J.
        • Maisey N.R.
        • Hughes S.
        • Fields P.
        • et al.
        The impact of comprehensive geriatric assessment interventions on tolerance to chemotherapy in older people.
        Br J Cancer. 2015 Apr 28; 112: 1435-1444
        • Welsh T.J.
        • Gordon A.L.
        • Gladman J.R.
        Comprehensive geriatric assessment--a guide for the non-specialist.
        Int J Clin Pract. 2014 Mar; 68: 290-293
        • Rubenstein L.Z.
        • Stuck A.E.
        • Siu A.L.
        • Wieland D.
        Impacts of geriatric evaluation and management programs on defined outcomes: overview of the evidence.
        J Am Geriatr Soc. 1991 Sep; 39 (8S–16S; discussion 17S–18S)
        • Stuck A.E.
        • Siu A.L.
        • Wieland G.D.
        • Adams J.
        • Rubenstein L.Z.
        Comprehensive geriatric assessment: a meta-analysis of controlled trials.
        Lancet. 1993; 342: 1032-1036
        • Orum M.
        • Jensen K.
        • Gregersen M.
        • Meldgaard P.
        • Damsgaard E.M.
        Impact of comprehensive geriatric assessment on short-term mortality in older patients with cancer-a follow-up study.
        Eur J Cancer. 2019 Jun 1; 116: 27-34
        • Reuben D.B.
        • Maly R.C.
        • Hirsch S.H.
        • Frank J.C.
        • Oakes A.M.
        • Siu A.L.
        • et al.
        Physician implementation of and patient adherence to recommendations from comprehensive geriatric assessment.
        Am J Med. 1996 Apr; 100: 444-451
        • Baitar A.
        • Kenis C.
        • Moor R.
        • Decoster L.
        • Luce S.
        • Bron D.
        • et al.
        Implementation of geriatric assessment-based recommendations in older patients with cancer: a multicentre prospective study.
        J Geriatr Oncol. 2015; 6 (2015/09): 401-410
        • Balducci L.
        • Extermann M.
        • Carreca I.
        Management of breast cancer in the older woman.
        Cancer Control. 2001 Sep-Oct; 8: 431-441
        • Balducci L.
        Management of cancer in the elderly.
        Oncology (Williston Park). 2006 Feb; 20 (discussion 144, 146, 151–2): 135-143
        • Kristjansson S.R.
        • Nesbakken A.
        • Jordhy M.S.
        • Skovlund E.
        • Audisio R.A.
        • Johannessen H.
        • et al.
        Comprehensive geriatric assessment can predict complications in elderly patients after elective surgery for colorectal cancer: a prospective observational cohort study.
        Crit Rev Oncol Hematol. 2010; 76: 208-217
        • Neve M.
        • Jameson M.B.
        • Govender S.
        • Hartopeanu C.
        Impact of geriatric assessment on the management of older adults with head and neck cancer: a pilot study.
        J Geriatr Oncol. 2016; 7 (2016/02): 457-462
        • Hamaker M.E.
        • Vos A.G.
        • Smorenburg C.H.
        • de Rooij S.E.
        • van Munster B.C.
        The value of geriatric assessments in predicting treatment tolerance and all-cause mortality in older patients with cancer.
        Oncologist. 2012; 17: 1439-1449
        • Orum M.
        • Gregersen M.
        • Jensen K.
        • Meldgaard P.
        • Damsgaard E.M.S.
        Frailty status but not age predicts complications in elderly cancer patients: a follow-up study.
        Acta Oncol. 2018 Nov; 57: 1458-1466
        • Folstein M.F.
        • Robins L.N.
        • Helzer J.E.
        The mini-mental state examination.
        Arch Gen Psychiatry. 1983; 40: 812
        • Guigoz Y.
        • Vellas B.
        • Garry P.J.
        Assessing the nutritional status of the elderly: the mini nutritional assessment as part of the geriatric evaluation.
        Nutr Rev. 1996; 54: S59-S65
        • Jones C.J.
        • Rikli R.E.
        • Beam W.C.
        A 30-s chair-stand test as a measure of lower body strength in community-residing older adults.
        Res Q Exerc Sport. 1999; 70: 113-119
        • Podsiadlo D.
        • Richardson S.
        The timed "Up & Go": a test of basic functional mobility for frail elderly persons.
        J Am Geriatr Soc. 1991 Feb; 39: 142-148
        • Harris P.A.
        • Taylor R.
        • Thielke R.
        • Payne J.
        • Gonzalez N.
        • Conde J.G.
        Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.
        J Biomed Inform. 2009 Apr; 42: 377-381
        • van der Vlies E.
        • Kurk S.A.
        • Roodhart J.M.L.
        • Gerritse F.L.
        • Pelgrim T.C.
        • Vos J.M.
        • et al.
        The relevance of geriatric assessment for older patients receiving palliative chemotherapy.
        J Geriatr Oncol. 2020; 11: 482-487
        • Sundhedsstyrelsen D.
        Screening for Tarmkræft.
        (Available at:) (Accessed 02/25, 2020)
        • Puts M.T.E.
        • Sattar S.
        • Kulik M.
        • MacDonald M.E.
        • McWatters K.
        • Lee K.
        • et al.
        A randomized phase II trial of geriatric assessment and management for older cancer patients.
        Support Care Cancer. 2018; 26 (2018/01): 109-117
        • Hempenius L.
        • Slaets J.P.
        • van Asselt D.
        • de Bock G.H.
        • Wiggers T.
        • van Leeuwen B.L.
        Outcomes of a geriatric liaison intervention to prevent the development of postoperative delirium in frail elderly cancer patients: report on a multicentre, randomized.
        Controlled Trial PLoS One. 2013 Jun 19; 8e64834
        • Ommundsen N.
        • Wyller T.B.
        • Nesbakken A.
        • Bakka A.O.
        • Jordhoy M.S.
        • Skovlund E.
        • et al.
        Preoperative geriatric assessment and tailored interventions in frail older patients with colorectal cancer: a randomized controlled trial.
        Colorectal Dis. 2018 Jan; 20: 16-25
        • Jeppesen S.S.
        • Matzen L.
        • Brink C.
        • Bliucukiene R.
        • Kasch S.
        • Schytte T.
        • et al.
        Impact of comprehensive geriatric assessment on quality of life, overall survival, and unplanned admission in patients with non-small cell lung cancer treated with stereotactic body radiotherapy.
        J Geriatr Oncol. 2018; 9 (2018/11): 575-582
        • Mazzola M.
        • Bertoglio C.
        • Boniardi M.
        • Magistro C.
        • De Martini P.
        • Carnevali P.
        • et al.
        Frailty in major oncologic surgery of upper gastrointestinal tract: how to improve postoperative outcomes.
        Eur J Surg Oncol. 2017 Aug; 43: 1566-1571
        • Wildiers H.
        • Heeren P.
        • Puts M.
        • Topinkova E.
        • Janssen-Heijnen M.L.
        • Extermann M.
        • et al.
        International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer.
        J Clin Oncol. 2014 Aug 20; 32: 2595-2603
        • Kristjansson S.R.
        • Nesbakken A.
        • Jordhoy M.S.
        • Skovlund E.
        • Audisio R.A.
        • Johannessen H.O.
        • et al.
        Comprehensive geriatric assessment can predict complications in elderly patients after elective surgery for colorectal cancer: a prospective observational cohort study.
        Crit Rev Oncol Hematol. 2010 Dec; 76: 208-217
        • Ommundsen N.
        • Wyller T.B.
        • Nesbakken A.
        • Jordhoy M.S.
        • Bakka A.
        • Skovlund E.
        • et al.
        Frailty is an independent predictor of survival in older patients with colorectal cancer.
        Oncologist. 2014 Dec; 19: 1268-1275
        • MAHONEY F.I.
        • BARTHEL D.W.
        Functional evaluation: the Barthel index.
        Md State Med J. 1965; 14: 61-65
        • Pfeffer R.I.
        • Kurosaki T.T.
        • Harrah Jr., C.H.
        • Chance J.M.
        • Filos S.
        Measurement of functional activities in older adults in the community.
        J Gerontol. 1982 May; 37: 323-329
        • Parmelee P.A.
        • Thuras P.D.
        • Katz I.R.
        • et al.
        Validation of the cumulative illness rating scale in a geriatric residential population.
        J Am Geriatr Soc. 1995; 43: 130-137
        • Sheikh J.I.
        • Yesavage J.A.
        Geriatric depression scale (GDS): recent evidence and development of a shorter version.
        Clin Gerontol. 1986; 5: 165-173